Pharmaceutical

Novo Nordisk to invest $2.3bn to expand Danish manufact...

The new investment will be used to expand the company’s existing active pharmace...

Ro pauses advertising of weight loss drug Wegovy amid s...

Telehealth company Ro has paused advertising of the obesity drug Wegovy as the d...

Obesity impairs brain responses to nutrients, even afte...

“There’s a biological process ongoing that really explains why people are strugg...

STAT+: Pharmalittle: U.S. Chamber sues over Medicare pr...

The FDA is seeking new suppliers to ease shortages of methotrexate, one of the m...

STAT+: Fed up with exorbitant health costs, employers a...

"Employers who are bearing the full risk of the cost of paying for health insura...

STAT+: The inside story of how data integrity issues ro...

Concerns over the integrity of key data led to major tumult at Laronde, a biotec...

Opinion: The court system is not ready for child custod...

As a result of these coming disputes, trans children and teenagers will be left ...

STAT+: Novartis to buy Chinook Therapeutics, developer ...

Novartis said it would purchase Chinook Therapeutics, picking up two drugs for a...

STAT+: Francis deSouza’s tenure at Illumina is a lesson...

The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represen...

Following board fight, Francis deSouza resigns as Illum...

Just two weeks after surviving an activist investor’s attempt to oust him from I...

STAT+: Kura Oncology highlights leukemia remission data...

A genetically targeted cancer drug from Kura Oncology has helped put more patien...

STAT+: FDA’s letter to medical device maker iRhythm is ...

The FDA issued a warning to device maker iRhythm for marketing its product for “...

Opinion: STAT+: Why we created a chatbot to help people...

The grim reality is there will never be enough trained therapists to meet the de...

Uproleselan sodium by GlycoMimetics for Multiple Myelom...

Uproleselan sodium is under clinical development by GlycoMimetics and currently ...

RT-002 by Revance Therapeutics for Upper Limb Muscle Sp...

RT-002 is under clinical development by Revance Therapeutics and currently in Ph...

Pimitespib by Otsuka Pharmaceutical for Metastatic Lung...

Pimitespib is under clinical development by Otsuka Pharmaceutical and currently ...